Behavioral Therapy Plus Naltrexone for Alcoholism
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Nov 2, 1999
Trial Information
Current as of July 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meets criteria for alcohol dependence, has not had more than one previous inpatient medical detoxification.
- • Consumes on average five standard drinks per day.
- • Able to maintain sobriety for five days (with or without the aid of detoxification medications) as determined by self-report, collateral report, and breathalyzer measurements.
- • Able to read and understand questionnaires and informed consent.
- • Lives within 50 miles of the study site.
- Exclusion Criteria:
- • Currently meets criteria for any other psychoactive substance dependency disorder.
- • Ever abused opiates.
- • Used psychoactive substance abuse, except marijuana, within the last 30 days as evidenced by patient report, collateral report, and urine drug screen.
- • Meets criteria for disorders of major depression, panic disorder, obsessive-compulsive disorder, post-traumatic stress syndrome, bipolar affective disorder, schizophrenia, or any other psychotic disorder or organic mental disorder.
- • Meets criteria for dissociate disorder or eating disorders.
- • Has current suicidal or homicidal ideation.
- • Need for maintenance or acute treatment with any psychoactive medication including antiseizure medications.
- • Current use of disulfiram (Antabuse).
- • Clinically significant medical problems that would impair participation or limit medication ingestion.
- • Hepatocellular disease.
- • Sexually active females of child bearing potential who are pregnant, nursing, or who are not using a reliable form of birth control.
- • Have current charges pending for a violent crime.
- • Does not have a stable living situation and a reliable source of collateral reporting.
- • Has taken an opiate antagonist drug in the last month.
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Ray Anton, MD
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials